MIRADX
Live / Allowed — Approved for publication (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99573201
- Mark type
- Stylized text
- Filed
- 31 Dec 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs for medical purposes and also including collection tubes with caps, all with or without stabilizing reagents and with printed instructions, printed mailing labels, and flat pack cardboard mailing boxes
- Class 009 — Scientific and electric apparatus: DNA collection kit comprised primarily of DNA collection laboratory swabs and swab handles and also including printed instructions, shipping labels and transport packaging
- Class 010 — Medical apparatus: Specimen collection kits for use in genetic testing comprised primarily of saliva containers for medical purposes sold empty and also including printed instructions, shipping labels and transport packaging; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes
- Class 042 — Scientific and technological services: Research and development services in the pharmaceutical and biotechnology fields, namely, research for and development of gene-based laboratory tests based on genomic research conducted on micro RNAs; providing scientific information in the field of research for gene-based laboratory tests based on genomic research conducted on micro RNAs
- Class 044 — Medical, beauty and agricultural services: Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity and response in connection with cancer treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity and response in connection with cancer treatments
Owner
- Mira DX, Inc., San Francisco, CA, US
Prior registrations
Prosecution history
- 31 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 31 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 31 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 31 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 25 Mar 2026 — ASSIGNED TO EXAMINER
- 31 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 31 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Dec 2025 — NEW APPLICATION ENTERED